Glucose hypometabolism is highly localized, but lower cortical thickness and brain atrophy are widespread in cognitively normal older adults

Am J Physiol Endocrinol Metab. 2014 Jun 1;306(11):E1315-21. doi: 10.1152/ajpendo.00067.2014. Epub 2014 Apr 15.

Abstract

Several studies have suggested that glucose hypometabolism may be present in specific brain regions in cognitively normal older adults and could contribute to the risk of subsequent cognitive decline. However, certain methodological shortcomings, including a lack of partial volume effect (PVE) correction or insufficient cognitive testing, confound the interpretation of most studies on this topic. We combined [(18)F]fluorodeoxyglucose ([(18)F]FDG) positron emission tomography (PET) and magnetic resonance (MR) imaging to quantify cerebral metabolic rate of glucose (CMRg) as well as cortical volume and thickness in 43 anatomically defined brain regions from a group of cognitively normal younger (25 ± 3 yr old; n = 25) and older adults (71 ± 9 yr old; n = 31). After correcting for PVE, we observed 11-17% lower CMRg in three specific brain regions of the older group: the superior frontal cortex, the caudal middle frontal cortex, and the caudate (P ≤ 0.01 false discovery rate-corrected). In the older group, cortical volumes and cortical thickness were 13-33 and 7-18% lower, respectively, in multiple brain regions (P ≤ 0.01 FDR correction). There were no differences in CMRg between individuals who were or were not prescribed antihypertensive medication. There were no significant correlations between CMRg and cognitive performance or metabolic parameters measured in fasting plasma. We conclude that highly localized glucose hypometabolism and widespread cortical thinning and atrophy can be present in older adults who are cognitively normal, as assessed using age-normed neuropsychological testing measures.

Keywords: aging; cerebral glucose metabolism; cortical thickness; cortical volume; positron emission tomography.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Aging / metabolism
  • Aging / pathology*
  • Antihypertensive Agents / adverse effects
  • Atrophy
  • Blood Glucose / metabolism
  • Brain / pathology*
  • Brain Chemistry / physiology
  • Cerebral Cortex / pathology*
  • Cognition / physiology
  • Executive Function / physiology
  • Female
  • Fluorodeoxyglucose F18
  • Glucose / metabolism*
  • Humans
  • Image Processing, Computer-Assisted
  • Kinetics
  • Magnetic Resonance Imaging
  • Male
  • Memory, Long-Term / physiology
  • Memory, Short-Term / physiology
  • Middle Aged
  • Neuropsychological Tests
  • Positron-Emission Tomography
  • Radiopharmaceuticals
  • Young Adult

Substances

  • Antihypertensive Agents
  • Blood Glucose
  • Radiopharmaceuticals
  • Fluorodeoxyglucose F18
  • Glucose